Current therapies for Alzheimer’s disease (AD) includes acetylcholinesterase inhibitors, NMDA receptor antagonists, and amyloid beta (Aβ)/Tau-targeting drugs. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.